| Financial Year |
March 31 2022 |
| Monetary Funds |
37,758,324.18 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
7,605,294.19 |
| Advances to Suppliers |
9,696,983.45 |
| Other Receivables |
2,575,448.32 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,008,289.15 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
25,598,094.97 |
| Total Current Assets |
89,242,434.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
30,301,169.23 |
| Under-construction Projects |
720,922,011.47 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,083,572,065.16 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
144,433,614.42 |
| Deferred Income Tax Assets |
31,354,323.19 |
| Other Non-Current Assets |
472,815,008.29 |
| Sub-Total of Non-Current Assets |
2,491,566,504.74 |
| Total Assets |
2,580,808,939.00 |
| Short-Term Loans |
100,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
322,295,506.69 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,617,272.05 |
| Taxes Payable |
1,368,425.09 |
| Interest Payable |
101,397,233.43 |
| Dividend Payable |
-- |
| Other payables |
932,917,767.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
86,936,451.04 |
| Other Current Liabilities |
279,528.90 |
| Sub-Total of Current Liabilities |
1,454,565,173.17 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
48,937,152.14 |
| Special Payable |
-- |
| Estimatied Liabilities |
28,460,220.76 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
83,914,689.77 |
| Total Liabilities |
1,538,479,862.94 |
| Paid-In Capital(Or Share Stock) |
337,822,022.00 |
| Capital Surplus |
557,711,662.04 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
63,520,000.00 |
| Undistributed Profits |
-483,366,442.62 |
| Minority Stockholder's Interest |
693,681,834.64 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
348,647,241.42 |
| Owner's Equity（Stockholder's Equity） |
1,042,329,076.06 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,580,808,939.00 |
